Ophthalmic Business News

WAIKOLOA, Hawaii — The No Surprises Act will impact some ophthalmic practices, particularly those with an ASC, Allison W. Shuren, MSN, JD, said during a presentation here.

As Bausch Health approaches planned initial public offerings, the company is looking forward to the opportunity to grow its eye health business.

ONL Therapeutics has closed its second tranche of Series B financing, which totaled $46.9 million, according to a press release.

Both at the end of the year and in the beginning of the following year, many physicians focus on charitable planning.

Healio/Ocular Surgery News is celebrating its 40-year anniversary and will commemorate its history throughout 2022.

Alcon has completed its acquisition of Ivantis, gaining rights to the Hydrus microstent in the process, according to a press release.

The top ophthalmology features in 2021 discussed champagne cork safety and the dangers of ocular exposure to hand sanitizer.

AffaMed Therapeutics and Hanmi Pharmaceutical have entered into a licensing agreement granting AffaMed exclusive rights to develop and commercialize risuteganib in Greater China, according to a press release.

Physicians interested in estate or asset protection planning inevitably inquire about the use of trusts. Certainly, trusts can play significant roles in many physicians’ estate and/or asset protection planning.

Omeros has completed its sale of Omidria to Rayner Surgical Group, according to a press release.